# Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

> **NCT01359462** · PHASE1 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 11 (actual)

## Conditions studied

- Hepatic Cirrhosis
- Ascites

## Interventions

- **DRUG:** tolvaptan

## Key facts

- **NCT ID:** NCT01359462
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2009-11
- **Final completion:** 2010-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2011-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359462, "Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01359462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*